With a single sample and test, healthcare professionals can confidently provide the right diagnosis and best course of treatment for patients when the COVID-19 pandemic and influenza season overlap.
The SARS-CoV-2 Rapid Antigen Test Nasal provides rapid results for fast decision-making at the Point of Care. Nasal sampling is less invasive, which can reduce patient discomfort, and minimize the duration of the procedure as well as the risk of sneezing or coughing. Nasal swab samples may be self-collected by patients under supervision, offering further protection for healthcare professionals.
Roche Diagnostics serves customers spanning the entire healthcare spectrum - from commercial laboratories, research institutions and hospitals to physicians and patients.
Doing now what patients need next
We believe it’s urgent to deliver medical solutions right now – even as we develop innovations for the future.
Get to know Roche
Get a real taste of the business and culture of one of the world’s great research-based healthcare companies.
